Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R ... - APA OTS (Pressemitteilung)

Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R ... APA OTS (Pressemitteilung), Austria Maidenhead, England (ots/PRNewswire) - - Two-year Data From COMET Study in Early Active Moderate-to-Severe Rheumatoid Arthritis Indicated Sustained Halt of Progressive Joint Damage - New Analyses From ASCEND Study in Ankylosing Spondylitis Indicated ... Better access to info and dialogue with HCPs on sexual issues for ... EurekAlert (press release) all 30 news articles

Five-Year Data Demonstrate Initial Use of Abbott's HUMIRA ... - Insciences Organisation

Five-Year Data Demonstrate Initial Use of Abbott's HUMIRA ... Insciences Organisation, Switzerland ... psoriatic arthritis (PsA), moderate to severe chronic plaque psoriasis, active ankylosing spondylitis (AS), moderate to severe Crohn's disease and moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in the United States and Europe. ...

Enbrel(R) Receives Positive European Recommendations for a New ... - PR Newswire UK (press release)

Enbrel(R) Receives Positive European Recommendations for a New ... PR Newswire UK (press release), UK Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. Treatment of adults with moderate to severe plaque psoriasis who failed to respond to, or who have a contraindication to, ...

Enbrel(R) Receives Positive European Recommendations for a New ... - Merinews

Enbrel(R) Receives Positive European Recommendations for a New ... Merinews, India ... Enbrel has been proven to be effective in, and isApproved for, the treatment of rheumatoid arthritis, plaque psoriasis,paediatric plaque psoriasis, polyarticular juvenile idiopathic arthritis,psoriatic arthritis and ankylosing spondylitis.